Using personalized immune-humanized xenograft mouse models to predict immune checkpoint responses in malignant melanoma: potential and hurdles

被引：3
|
作者：
Helleday, T. [1 ,2 ]
机构：
[1] Univ Sheffield, Dept Oncol & Metab, Weston Pk Canc Ctr, Sheffield, S Yorkshire, England
[2] Karolinska Inst, Dept Oncol Pathol, Sci Life Lab, Stockholm, Sweden
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷 / 02期
基金：
瑞典研究理事会;
关键词：
PD-1; BLOCKADE;
D O I：
10.1016/j.annonc.2019.11.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：167 / 168
页数：2
相关论文
共 50 条
  • [31] Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models
    Jo Waaler
    Line Mygland
    Anders Tveita
    Martin Frank Strand
    Nina Therese Solberg
    Petter Angell Olsen
    Aleksandra Aizenshtadt
    Marte Fauskanger
    Kaja Lund
    Shoshy Alam Brinch
    Max Lycke
    Elisabeth Dybing
    Vegard Nygaard
    Sigurd Læines Bøe
    Karen-Marie Heintz
    Eivind Hovig
    Clara Hammarström
    Alexandre Corthay
    Stefan Krauss
    Communications Biology, 3
  • [32] Early peripheral T-cell responses predict oncological outcome to checkpoint immune blockade in metastatic melanoma
    Fairfax, B.
    Taylor, C. A.
    Watson, R. A.
    Nassiri, I.
    Fang, H.
    Mahe, E.
    Cooper, R.
    Danielli, S.
    Woodcock, V. K.
    Traill, Z.
    Knight, J. C.
    Payne, M.
    Middleton, M. R.
    ANNALS OF ONCOLOGY, 2019, 30
  • [33] Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models
    Waaler, Jo
    Mygland, Line
    Tveita, Anders
    Strand, Martin Frank
    Solberg, Nina Therese
    Olsen, Petter Angell
    Aizenshtadt, Aleksandra
    Fauskanger, Marte
    Lund, Kaja
    Brinch, Shoshy Alam
    Lycke, Max
    Dybing, Elisabeth
    Nygaard, Vegard
    Boe, Sigurd Laeines
    Heintz, Karen-Marie
    Hovig, Eivind
    Hammarstrom, Clara
    Corthay, Alexandre
    Krauss, Stefan
    COMMUNICATIONS BIOLOGY, 2020, 3 (01)
  • [34] Potential role of TGF-beta signaling in immune-checkpoint-therapy-induced resistance in malignant melanoma
    Loeffek, S.
    Horn, S.
    Dujardin, P.
    Hoelzel, M.
    Schadendorf, D.
    Helfrich, I.
    EXPERIMENTAL DERMATOLOGY, 2018, 27 (03) : E63 - E64
  • [35] Humanized Mouse Models to Study Cell-Mediated Immune Responses to Liver-Stage Malaria Vaccines
    Good, Michael F.
    Hawkes, Michael T.
    Yanow, Stephanie K.
    TRENDS IN PARASITOLOGY, 2015, 31 (11) : 583 - 594
  • [36] Evaluation of a TGN1412 analogue using in vitro assays and two immune humanized mouse models
    Yan, Hangyi
    Bhagwat, Bhagyashree
    Sanden, David
    Willingham, Aarron
    Tan, Alick
    Knapton, Alan D.
    Weaver, James L.
    Howard, Kristina E.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2019, 372 : 57 - 69
  • [37] Promotion of immunogenicity using epigenetic modulation and immune checkpoint inhibition in mouse models of breast cancer
    Torres, Evanthia T. Roussos
    Ma, Hayley
    Christmas, Brian
    Armstrong, Todd
    Jaffee, Elizabeth M.
    CANCER RESEARCH, 2017, 77
  • [38] Using machine learning algorithms to predict response and toxicity to immune checkpoint inhibitors (ICIs) in melanoma patients.
    Johannet, Paul
    Coudray, Nicolas
    Jour, George
    Donnelly, Douglas MacArthur
    Bajaj, Shirin
    Moran, Una
    Dawood, Zarmeena
    Nomikou, Sofia
    Kim, Randie H.
    Pavlick, Anna C.
    Weber, Jeffrey S.
    Tsirigos, Aristotelis
    Osman, Iman
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [39] Analysis of human innate immune responses to PRINT fabricated nanoparticles with cross validation using a humanized mouse model
    Robbins, Gregory R.
    Roberts, Reid A.
    Guo, Haitao
    Reuter, Kevin
    Shen, Tammy
    Sempowski, Gregory D.
    McKinnon, Karen P.
    Su, Lishan
    DeSimone, Joseph M.
    Ting, Jenny P. -Y.
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2015, 11 (03) : 589 - 599
  • [40] Potential new screening model for immune checkpoint inhibitors using CAM-PDX models
    Daizumoto, Kei
    Uto, Yoshihiro
    Uehara, Hisanori
    Nishiyama, Mitsuki
    Tomida, Ryotaro
    Fukawa, Tomoya
    Takahashi, Masayuki
    CANCER SCIENCE, 2024, 115 : 1513 - 1513
12345